Eli Tomac is back on his bike, practicing for a return to the SuperMotocross League in May. “Back at it,” Tomac posted on social media. “Goal as of now is [Pro Motocross] Round 1, would love to sneak ...

Eli Tomac is back on his bike, practicing for a return to the SuperMotocross League in May. "Back at it," Tomac posted on social media. "Goal as of now is [Pro Motocross] Round 1, would love to ...

Eli Tomac is back on his bike, practicing for a return to the SuperMotocross League in May. "Back at it," Tomac posted on social media. "Goal as of now is [Pro Motocross] Round 1, would love to ...

Eli Tomac, 32, announced earlier this year that he renewed his contract with Monster Energy Yamaha Star Racing for 2025. That was great news for his fans; the bad news was that he would make this ...

Eli Tomac also won in 2015 but has not yet returned to racing after breaking his fibula earlier in the year. Eight riders have won the most recent eight races at MetLife. Roczen leads the active ...

Chase Sexton placed first overall in Round 13 of the 2025 Supercross season in Philadelphia, maintaining his place behind standings leader Cooper Webb. Meanwhile, the injured Eli Tomac of Cortez ...

No active rider has more than a single win, with Barcia joined by Cooper Webb in 2019 and Ken Roczen in 2016. Eli Tomac also won in 2015 but has not yet returned to racing after breaking his fibula ...

Eli Lilly reported promising results from a study of its experimental oral drug that could rival popular injections to treat obesity and diabetes. By Rebecca Robbins and Gina Kolata Encouraging ...

Investing.com -- Novo Nordisk (NYSE:NVO) shares sank more than 7% in Copenhagen after Eli Lilly (NYSE:LLY) released promising trial results for its experimental obesity pill, orforglipron ...

Eli Lilly and Company discovers, develops, and markets human pharmaceuticals in the United States, Europe, China, Japan, and internationally. The company offers Basaglar, Humalog, Humalog Mix 75/ ...

Eli Lilly stock has been a big-time winner over the last couple of years, but looming tariffs are worrying some investors. The pharmaceutical sector could be the next industry to face sweeping ...

Eli Lilly and Novo Nordisk dominate the billion-dollar weight loss drug market. Lilly has announced positive trial results from a candidate that could be a game changer in this area of high demand ...